(2010). A: Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod
(2005). A: Ovarian androgens but not estrogens correlate with the degree of systemic inflammation observed during controlled ovarian stimulation. Gynecol Endocrinol
(2009). A: Testosterone and dehydroepiandrosterone sulphate levels and IVF/ICSI results. Gynecol Endocrinol
(1992). Abraham GE: Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studies.
(2007). Akman MA: Comparisons of follicular levels of sex steroids, gonadotropins and insulin like growth factor-1 (IGF-1) and epidermal growth factor (EGF) in poor responders and normoresponders patients undergoing ovarian stimulation with GnRH antagonist.
(2008). AN: Short-term androgen priming with use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial. Hum Reprod
(2007). Aneuploidy rates in embryos from women with prematurely declining ovarian function: a pilot study. Fertil Steril
(2009). Atabekoğlu CS: Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders.
(1999). Casson PR: Changes in adrenocortical function with aging and therapeutic implications. Semin Reprod Endocrinol
(2006). CY: Androgen priming using aromatase inhibitor and hCG during earlyfollicular-phase GnRH antagonist down-regulation in modified antagonist protocol. Hum Reprod
(1996). Delivery of dehydroepiandrosterone to premenopausal women: effect of
(2010). DH: Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live birth chances in women with severely ovarian reserve. Fertil Steril
(2010). DH: Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: Direct evidence from preimplantation genetic screening (PGS). Reprod Biol Endocrinol
(2010). DH: Improvement in diminished ovarian reserve after dehydroepiandrosterone (DHEA) supplementation. Reprod Biomed Online
(2009). DH: Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study. Reprod Biol Endocrinol
(2004). Dunkel L: Effects of testosterone, dihydrotestosterone, and 17 betaestradiol on human ovarian tissue survival in culture. Fertil Steril
(2006). Effect of dehydroepinadrosterone on oocytes and embryo yields, embryo grade and cell number in IVF. Hum Reprod
(2006). Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction-technique-a prospective, randomized, double-blind study. Hum Reprod
(2009). Ethics Committee of the American Society for Reproductive Medicine: Fertility treatment when the prognosis is very poor or futile. Fertil Steril
(2009). Evidence-based compared with reality-based medicine in obstetrics. Obstet Gynecol
(2009). Evidence-based medicine under attack. Obstet Gynecol